Stryker Corporation (SYK) Stock Forecast
US · Healthcare
Current price
$316.11
Market cap
$121.18B
Mean price target
$386.80
Implied upside
22.4%
Key takeaways
- Analysts rate Stryker Corporation a “Buy”, with a mean price target of $386.80 — about 22.4% upside from the current $316.11, based on 25 analysts.
- SYK is trading in the middle of its 52-week range, at 28% of the $281.00–$404.87 band.
- On valuation, SYK trades at a premium P/E of 158.4 and an EV/EBITDA of 100.3.
- Profitability looks weak: return on equity is 3.2%, with a free-cash-flow margin of 6.9%.
- Its balance sheet looks solid, with a current ratio of 2.11. Net debt/EBITDA stands at 9.1x.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 25 |
| Mean target | $386.80 |
| High target | $465.00 |
| Low target | $315.00 |
| Rating split (SB / B / H / S / SS) | 8 / 13 / 8 / 0 / 0 |
Price & trading
| Current price | $316.11 |
|---|---|
| Previous close | $313.68 |
| 52-week high | $404.87 |
| 52-week low | $281.00 |
| 50-day average | $311.05 |
| Beta | 0.79 |
Valuation
| P/E ratio | 158.37 |
|---|---|
| P/B ratio | 5.15 |
| EV / EBITDA | 100.33 |
| Dividend yield | 0.0% |
| Revenue per share | $15.70 |
| Book value per share | $59.94 |
Profitability
| Return on equity (ROE) | 3.2% |
|---|---|
| Return on assets (ROA) | 1.6% |
| Return on invested capital (ROIC) | 2.5% |
| Free-cash-flow margin | 6.9% |
| FCF yield | 0.3% |
Financial health
| Current ratio | 2.11 |
|---|---|
| Quick ratio | 1.25 |
| Debt / equity | 1.01 |
| Net debt / EBITDA | 9.13 |
| Interest coverage | 6.74 |
| Altman Z-score | 4.06 |
See the full SYK breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Stryker Corporation (SYK) share price?
- Stryker Corporation last traded at $316.11 with a market capitalisation of about $121.2B.
- What is the analyst price target for SYK?
- The mean analyst price target for Stryker Corporation is $386.80, roughly 22.4% above the latest price. The current consensus rating is “Buy”.
- Is SYK expensive on a P/E basis?
- Stryker Corporation currently trades on a price-to-earnings ratio of 158.4, with a price-to-book of 5.2.
- Where can I see Stryker Corporation's full financial metrics?
- Luminoso tracks SYK's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.